Patent Drawings for Medical Devices: 9 Proven Standards

A rejected figure rarely kills a medical device application, but it reliably costs you three months. USPTO formalities examiners issue a Notice of Draftsperson’s Patent Drawing Review over problems unrelated to whether the device works — hatching that swallows a reference numeral, a histology image filed as if it were line art, a color figure submitted without the petition that makes it admissible. Patent drawings for medical devices sit awkwardly: the subject matter is biological and often photographic, while the rules were written around solid black ink on white paper. Here are the nine standards that decide whether your figures clear formalities on the first pass, cited to the rules themselves.

Why Patent Drawings for Medical Devices Fail Examination

Medical device applications attract drawing objections at a higher rate than mechanical ones for three structural reasons, and none of them is sloppiness.

First, the devices are small and layered. A drug-eluting stent, a balloon catheter tip, or a bone screw with an internal cannula cannot be shown usefully in elevation alone. The disclosure lives in the cross-section, and cross-sections are where the hatching rules bite.

Second, a large share of the supporting evidence is photographic. Histology slides, fluorescence imaging, gel electrophoresis for a diagnostic assay — these are not drawings in the ordinary sense, and whether they are admissible at all turns on a specific provision rather than on examiner discretion.

Third, medical device companies routinely file a design patent on the housing or the screen interface alongside the utility case. The two filings are governed by different drawing rules that contradict each other on surface shading, and teams that reuse one set of figures for both filings create an objection on purpose without realising it.

The practical consequence is that formalities review is a distinct gate. An examiner can allow your claims and the draftsperson can still object to your figures, and you will not get the patent until both are satisfied.

Standard 1 and 2: The Ink and Paper Baseline of 37 CFR 1.84

The governing rule for utility figures is 37 CFR 1.84, titled “Standards for drawings.” Paragraph (a)(1) is the default and it is unambiguous: “India ink, or its equivalent that secures solid black lines, must be used for drawings.”

That single sentence is the baseline against which every exception in this article is measured. Black line art is admissible as of right. Everything else — color, photographs, grayscale imaging — is an exception that you must either qualify for or petition into.

Two consequences matter for device teams working from CAD or from clinical imaging:

• A grayscale render exported straight from SolidWorks or Fusion is not black line art. Soft gradient shading reproduces as mud at publication scale and draws an objection even though nothing in it is technically a photograph.
• An image that is reproduced in black and white is not the same as an image drawn in solid black lines. Desaturating a micrograph does not convert it into a compliant drawing.

The rule also governs the mechanical qualities of the sheet — margins, sheet size, line weight, and the legibility of characters after reduction. Those requirements are generic, and we cover them in detail in our guide to the USPTO patent drawing requirements under 37 CFR 1.84. What follows here is the subset that device and diagnostics filings actually trip over.

Standard 3: Sectional Views and Hatching That Survives Reduction

Cross-sections are where medical device figures earn their keep, and 37 CFR 1.84(h)(3) sets out how they must be rendered. Hatching “must be used to indicate section portions” and “must be made by regularly spaced oblique parallel lines” at an angle of “preferably 45°.”

The clause that actually causes objections is the last one: hatching “must not impede the clear reading of the reference characters.” In a multi-lumen catheter cross-section you may have eight or ten lead lines converging on a circle a few millimetres across in the printed patent. Standard-density hatch lines will cross every one of them.

Three techniques keep a dense section readable without departing from the rule:

1. Open a clear window in the hatching around each reference numeral rather than running the numeral on top of the lines. The rule requires regularly spaced lines across the section portion, not lines that obliterate the callout.
2. Vary the hatch angle between adjoining components so that the boundary between a polymer jacket and a braided reinforcement layer is readable as a boundary rather than as one continuous field.
3. Promote the congested area into an enlarged detail view on its own sheet, with the parent view carrying only the numerals that still fit.

Enlarged detail views also solve the reduction problem. Figures are reproduced at a fraction of their filed size, and a section that reads perfectly at A4 can become unreadable in the printed grant. Our breakdown of patent drawing sectional views works through the hatching conventions in more depth, including how to treat assemblies of dissimilar materials.

Standard 4: When Photographs Are the Only Practicable Medium

This is the provision that most directly serves medical and diagnostic filings, and it is routinely misquoted. Under 37 CFR 1.84(b)(1), “photographs, including photocopies of photographs, are not ordinarily permitted” — but they are acceptable where they are “the only practicable medium” for illustrating the claimed invention.

Crucially, the rule does not leave “only practicable medium” to be argued from first principles. It enumerates the accepted subjects: “electrophoresis gels, blots (e.g., immunological, western, Southern, and northern), autoradiographs, cell cultures (stained and unstained), histological tissue cross sections (stained and unstained), animals, plants, in vivo imaging, thin layer chromatography plates, crystalline structures, and, in a design patent application, ornamental effects.”

Read that list against a typical medical device or combination-product application and most of the photographic evidence you want to file is already named in it. Histological tissue cross sections showing the response at an implant interface, in vivo imaging demonstrating device placement, and stained cell cultures for a biocompatibility showing all fall squarely inside the enumerated categories.

What falls outside it is just as important. A photograph of the finished device on a bench is not within the list, because a line drawing is plainly a practicable medium for showing a physical instrument. Filing a product photograph because it is faster than commissioning a drawing is the single most common photographic objection in this field.

Note also what the rule does not promise. Photographs that are admissible are still subject to the general quality requirements — they must be of sufficient quality that all details are reproducible in the printed patent. An underexposed micrograph is objectionable on quality grounds even though its subject matter is squarely permitted.

Standard 5: Color Figures, the Petition, and the Number of Sets

Color is handled differently depending on which kind of application you are in, and the asymmetry catches people out.

In design applications, 37 CFR 1.84(a)(2) states plainly that color drawings are permitted. In a utility application they are not permitted as of right. They may be accepted only on “granting a petition filed under this paragraph explaining why the color drawings are necessary.”

The petition has two components that must accompany it:

• The fee set forth in 37 CFR 1.17(h).
• One (1) set of color drawings if submitted via the USPTO patent electronic filing system, or three (3) sets if not submitted electronically.

Because essentially all filing is now electronic, the practical answer is one set plus the fee plus the explanation — but the three-set requirement remains in the rule for paper submissions, and reciting it incorrectly in a response wastes a round.

The substantive hurdle is the word “necessary.” Color is necessary when the information is carried by the color itself and cannot survive conversion to black and white. A fluorescence image where two channels are distinguished only by hue qualifies. A heat map of stress distribution across a stent strut qualifies if the gradient is the disclosure. A rendering that is merely more attractive in color does not.

Teams filing in parallel at the EPO should not assume the two offices now behave alike, and we track the divergence in our note on EPO color patent drawings.

Standard 6 and 7: Design Patents on Housings and Screen Interfaces

Most medical device programmes file a design application on the enclosure, the handpiece, or the graphical interface on the device display. Those figures are governed by 37 CFR 1.152, not by the utility drawing conventions, and the two rules disagree in a way that produces self-inflicted objections.

On shading, 1.152 requires that “appropriate and adequate surface shading should be used to show the character or contour of the surfaces represented,” while prohibiting solid black: “solid black surface shading is not permitted except when used to represent the color black as well as color contrast.” A utility figure that uses a solid black fill to indicate a sealing gasket cannot simply be carried across into the design case.

On broken lines, 1.152 provides that they “may be used to show visible environmental structure, but may not be used to show hidden planes and surfaces that cannot be seen through opaque materials.” This is the mechanism by which you disclaim subject matter: the solid lines are the claimed design, the broken lines are context. For a surgical handpiece, claiming the grip profile in solid line while rendering the attached cannula in broken line is a deliberate scope decision, not a drafting detail.

Two further constraints are worth committing to memory. The rule does not permit “alternate positions of a design component, illustrated by full and broken lines in the same view.” An articulating jaw shown open and closed needs separate views. And where photographs are filed in a design application, they “must not disclose environmental structure but must be limited to the design claimed for the article” — which is precisely why a bench photograph of a device sitting on a drape fails.

The broader contrast between the two regimes is set out in our comparison of utility and design patent drawing differences.

Standard 8: Europe After Rule 46 EPC Was Deleted

Anyone working from a drawing checklist written before 2023 is citing a rule that no longer exists. Rule 46 EPC, headed “Form of the drawings,” was deleted with effect from 1 February 2023 as part of the EPO’s digital transformation package. The EPO’s own legal texts now show the rule simply as “(deleted).”

The requirements did not disappear; they changed their legal home. Rule 49 EPC governs the presentation of the application documents, and under Rule 49(2) it is the President of the EPO who determines the requirements for how those documents — drawings included — must be presented. The operative detail now sits in a Decision of the President and is restated in the EPO Guidelines, Part A, Chapter IX.

For a medical device filing this matters in two practical ways. A European attorney responding to a formalities communication will be answering a requirement sourced from the President’s decision, not from an Implementing Regulation, so a response that argues the text of old Rule 46 is answering the wrong instrument. And because the requirements are now set administratively rather than by the Administrative Council, they can be revised faster than the Rules themselves — which is exactly what happened when the EPO moved on color drawings.

Substantively, the EPO remains stricter than the USPTO on photographs. Keep a compliant line-drawing set for the European family even where the US case rests on micrographs admitted under 1.84(b)(1).

Standard 9: A Pre-Filing Drawing Checklist for Device Teams

Run this before the application leaves your hands. It catches the objections described above at the point where fixing them is free.

1. Every reference numeral in the specification appears in at least one figure, and every numeral in the figures appears in the specification.
2. No numeral is overlapped by a hatch line, a lead line, or a shading stroke in any sectional view.
3. Each photographic exhibit maps to a category named in 37 CFR 1.84(b)(1) — and if it does not, it has been replaced with a line drawing.
4. Any color figure in a utility case is accompanied by a petition under 1.84(a)(2), the 1.17(h) fee, and the correct number of sets.
5. The design figures use no solid black surface shading, and the broken-line boundary matches the scope you intend to claim.
6. Design views are sufficient to disclose the whole claimed article, with no alternate positions shown by full and broken lines in one view.
7. Enlarged detail views exist for every region that becomes illegible at reduced reproduction size.
8. The European set is line art only, prepared against the current EPO presentation requirements rather than deleted Rule 46 EPC.

Teams that work this list before filing generally clear formalities on the first pass. Teams that skip it discover the same eight items eighteen months later, in a Notice of Draftsperson’s Patent Drawing Review, while a competitor’s continuation is already published.

Get Your Device Figures Right the First Time

PerspireIP prepares USPTO, EPO and PCT-compliant figures for device, diagnostics and combination-product filings — sectional views that stay readable at reduction, photographic exhibits matched to the categories the rules actually name, and matched utility and design sets that do not contradict each other. See our patent drawing services, or talk to our team about an upcoming filing.

Frequently Asked Questions